Hemokinetitherm® Fluid Warmer

Products	Hemokinetitherm® Fluid Warmer
Company	Dupaco, Inc.
Item	Hemokinetitherm® Fluid Warmer
Features	New solid-state proportional controller which insures precise temperature accuracy. Back-up temperature controller prevents temperature from exceeding 39°C. "Power On" and "Heater On" indicator lights. Simple operation...just plug into power, add water, and insert hemocoil. Convenient carrying handle. Audible high temperature alarm system. Disposable Hemocoils (10/Box) available
Description	The Hemokinetitherm is a ruggedly built, simple to operate fluid warmer designed to provide a stable temperature for the controlled warming of blood or other fluids being transfused to a patient. This temperature is maintained by a water reservoir which is heated by two 150-watt heaters regulated by a proportional controller which is backed up by a thermoswitch. Blood is warmed to a uniform temperature as it flows through a disposable, pre-formed, sterile and leak proof Hemocoil tube, which is immersed in the water bath. The Hemokinetitherm requires less than 7 minutes to reach operating temperature.
Info	Dupaco, Inc. Customer Service: 800.546.4550 Web site: http://www.dupacoinc.com/

TAG: Hemokinetitherm reg Fluid Warmer

...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...

Medicine Products:

Prazosin (Minipress), Serum or Plasma PPA, Urine Potassium, Plasma or Serum Porphyrins, Urine

(Date:9/5/2008)...a nonprofit organization,devoted to improving publ...e launch of a new FDA Web site created to help the...er (DTC) advertising of prescription,medications. ...ising," is,hosted by the FDA,s Center for Drug Eva...in partnership with EthicAd. For details, visit, h...

(Date:9/5/2008)...site shouldn,t overreact or stop taking them , ....S. Food and Drug Administration has started listi...tial safety issues, the agency said Friday. , ... we have begun analysis to determine whether there...ion," Dr. Gerald Dal Pan, director of the FDA,s Of...

(Date:9/4/2008)...- A groundbreaking program,dealing with the deteri...en, their shorter life spans, unmet gender specifi...Wednesday, September 17 at White Plains,Hospital. ...estchester,medical and psychiatric societies will ...el Tiger, Ph.D., Dr. Legatto, an internationally ...

(Date:9/4/2008)... shortchanging their golden years by tapping into ...y of Illinois expert who has studied the federal r... than three of every four Americans trim their mon...enefits early, a choice many might forego if they ...uences, law professor Richard L. Kaplan says. , ...

Breaking Medicine News(10 mins):Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2 Health News:FDA to List Drugs Under Review for Safety Issues 2 Health News:New guide explores making the most of Social Security 2 Health News:New guide explores making the most of Social Security 3

[0] Prescription Drug Advertising Subject of New FDA Web Site for Consumers [2] FDA to List Drugs Under Review for Safety Issues [0] The Decline of Males, Why They Die First; at White Plains Hospital September 17 [0] New guide explores making the most of Social Security

...Farber Cancer Institute have identified a protein ... cells. Humans have a similar protein, although it...archers whose work //is published in this week's i...ki, is supported by the NIH's National Institute o...

...the most common form of dementia in the elderly wi...rioration, and // behavioral changes. An early stu...possible use in treating Alzheimer's disease in pe...ers say they found that treatment of a mouse form ...

...ently one of the most common male cancers and the ...dings from a recent study suggests that green tea ...cted in a mouse model of human prostate cancer, sh...present in the drink combat the disease on multipl...

...he use of hormone replacement therapy among breast...e results indicate an unacceptably high rate of re...ed on the study in part because more women are sur... to the same menopausal symptoms as other women. T...

Other Medicine News:

HIV blocking protein in Monkey New Treatment Option For Alzheimer's Disease Green Tea Might Help Patients With Prostate Cancer The Link Between HRT And Recurrence of Breast Cancer

(Date:9/5/2008)...Extracted From a Simple Blood Draw Have,the Potent...a Wide Range of Indic...Genomics is Currently Developing a B...Israel and JERSEY CITY, New Jersey, September 5,/P...SDQ: ROSG), a leader in,the development of microRN...

(Date:9/4/2008)...eal-time PCR testing for the diagnostic ...ept. 4 /- The U.S. Food & Drug,Admini...Man(R) HBV Test,the first assay for quantitating ...t uses Roche,s real-time PCR technology to quantif...,s blood. Doctors may use viral load,testing resul...

(Date:9/4/2008)...Women at More Than 100 Sites in the U.S., ANN ARB...uticals, a,privately-held biopharmaceutical compan...compounds to treat endocrine, metabolic and,cardio...itiated a second,Phase 3 clinical trial of Ophena(...ree oral therapy in development for the treatment ...

(Date:9/4/2008)...tification for Targeted Therapies Tha...TINGTON BEACH, Calif., and AMSTERDAM, Netherlands,...n molecular cancer diagnostics,today announced th...that,allows physicians to quantitatively determine...or (ER), progesterone receptor (PR) and Human Epid...

[0] Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum [0] FDA Approves First Hepatitis B Viral Load Test [0] QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome [0] Agendia Launches TargetPrint(R) for Breast Cancer Patients

...ech (ACTI.ST), today,announced new positive clinic...reatment of prostate cancer. , By step-wise dose e...ieved, which corresponds to a doubling of the prev... of 0.5 mg/day. This,means that a step-wise intra-... to be administered in future clinical trials. , "...

...eragenix Pharmaceuticals,Inc. (OTCBB:CGXP), a bio...se and dermatology, today announced that a cathete...irtually no biofilm,formation in a 21 day study., ...Ceragenins,were soaked daily in a phosphate-suffer...ay 21, the catheters were challenged with,an inocu...

Other Medicine Technology:Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer 2 Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2 Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3

Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study